Search Count: 15
All
Selected
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2024-12-25 Classification: HYDROLASE Ligands: CIT, EDO, VU4, UNX |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2024-02-07 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: TAM, UNX, EDO, 7R8, PEG, CIT, PG4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2024-01-31 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: EDO, UNX, GBS, CIT, CA, PG4 |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2023-07-05 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U0R |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: TKX |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: TNI |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U1J |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U1R |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U26 |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U2B |
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U2I |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-05-26 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2021-05-26 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-05-26 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-05-26 Classification: VIRAL PROTEIN Ligands: NAG |